公开(公告)号：US11887734B2

公开(公告)日：2024-01-30

申请号：US17838148

申请日：2022-06-10

Applicant: Elucid Bioimaging Inc.

Inventor： Andrew J. Buckler ,  Ulf Hedin ,  Ljubica Matic ,  Matthew Phillips

IPC: G06N20/00 ,  G16H50/20 ,  G16H20/10 ,  G16H50/50 ,  A61B6/00

CPC classification number: G16H50/20 ,  G06N20/00 ,  G16H20/10 ,  G16H50/50 ,  A61B6/504 ,  A61B6/5217

Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a lipid-lowering therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.

公开(公告)号：US20230420144A1

公开(公告)日：2023-12-28

申请号：US18240206

申请日：2023-08-30

Applicant: Elucid Bioimaging Inc.

Inventor： Andrew J. Buckler ,  Ulf Hedin ,  Ljubica Matic ,  Matthew Phillips

IPC: G16H50/50 ,  G06T7/00 ,  G16B5/00 ,  G16H50/70 ,  G16H20/10

CPC classification number: G16H50/50 ,  G06T7/0012 ,  G06T2207/30101 ,  G16H50/70 ,  G16H20/10 ,  G16B5/00

Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a lipid-lowering therapy for a patient with known or suspected atherosclerotic cardiovascular disease, such as atherosclerosis.

公开(公告)号：US20230386634A1

公开(公告)日：2023-11-30

申请号：US18232231

申请日：2023-08-09

Applicant: Elucid Bioimaging Inc.

Inventor： Andrew J. Buckler ,  Ulf Hedin ,  Ljubica Matic ,  Matthew Phillips

IPC: G16H20/10 ,  G16B5/00

CPC classification number: G16H20/10 ,  G16B5/00

Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of an anti-inflammatory therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.

公开(公告)号：US20230245775A1

公开(公告)日：2023-08-03

申请号：US18113944

申请日：2023-02-24

Applicant: Elucid Bioimaging Inc.

Inventor： Andrew J. Buckler ,  Ulf Hedin ,  Ljubica Matic ,  Matthew Phillips

IPC: G16H50/20 ,  G16H20/10 ,  G16H50/50

CPC classification number: G16H50/20 ,  G16H20/10 ,  G16H50/50 ,  A61B6/504

Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a lipid-lowering therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.

公开(公告)号：US20230237759A1

公开(公告)日：2023-07-27

申请号：US18166284

申请日：2023-02-08

Applicant: ELUCID BIOIMAGING INC.

Inventor： Andrew J. BUCKLER ,  Kjell JOHNSON ,  Xiaonan MA ,  Keith A. MOULTON ,  Mark A. BUCKLER ,  Vladimir VALTCHINOV ,  David S. PAIK

IPC: G06V10/25 ,  G06T7/00 ,  G06T7/11 ,  G06N20/00 ,  G06N3/08 ,  G06T5/00 ,  G06T3/00 ,  G06V20/69 ,  G06F18/24 ,  G06F18/211 ,  G06F18/214 ,  G06V10/764

CPC classification number: G06V10/25 ,  G06T7/0012 ,  G06T7/11 ,  G06N20/00 ,  G06N3/08 ,  G06T5/003 ,  G06T3/00 ,  G06V20/69 ,  G06F18/24 ,  G06F18/211 ,  G06F18/2148 ,  G06V10/764 ,  G06T2207/10132 ,  G06T2207/10081 ,  G06T2207/10088 ,  G06T2207/10101 ,  G06T2207/10104 ,  G06T2207/10108 ,  G06T2207/10048 ,  G06T2207/20081 ,  G06T2207/30096 ,  G06T2207/30104

Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.

公开(公告)号：US11607179B2

公开(公告)日：2023-03-21

申请号：US17328417

申请日：2021-05-24

Applicant: ELUCID BIOIMAGING INC.

Inventor： Andrew J. Buckler ,  Kjell Johnson ,  Xiaonan Ma ,  Keith A. Moulton ,  Mark A. Buckler ,  Vladimir Valtchinov ,  David S. Paik

IPC: G06T7/00 ,  A61B5/00 ,  G06T5/00 ,  G06T5/20 ,  G06T11/00 ,  G06T11/60 ,  A61B6/00 ,  G16H30/40 ,  G06N3/08 ,  A61B5/103 ,  G16H50/20 ,  G16H50/50 ,  G16H10/60 ,  A61B5/02 ,  A61B5/055 ,  A61B8/08 ,  A61B5/107 ,  A61B6/03 ,  A61B5/145

Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.

公开(公告)号：US20230005582A1

公开(公告)日：2023-01-05

申请号：US17838146

申请日：2022-06-10

Applicant: Elucid Bioimaging Inc.

Inventor： Andrew J. Buckler ,  Ulf Hedin ,  Ljubica Matic ,  Matthew Phillips

IPC: G16H20/10 ,  G16B5/00

Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of an anti-inflammatory therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.

公开(公告)号：US20220409160A1

公开(公告)日：2022-12-29

申请号：US17838140

申请日：2022-06-10

Applicant: Elucid Bioimaging Inc.

Inventor： Andrew J. Buckler ,  Ulf Hedin ,  Ljubica Matic ,  Matthew Phillips

IPC: A61B6/00 ,  A61B5/055 ,  A61B6/03 ,  G06T7/00

Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a combination of any two or more therapies selected from a lipid-lowering therapy, an anti-inflammatory therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.

公开(公告)号：US20220406459A1

公开(公告)日：2022-12-22

申请号：US17838148

申请日：2022-06-10

Applicant: Elucid Bioimaging Inc.

Inventor： Andrew J. Buckler ,  Ulf Hedin ,  Ljubica Matic ,  Matthew Phillips

IPC: G16H50/20 ,  G16H20/10 ,  G16H50/50

Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a lipid-lowering therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.

公开(公告)号：US20220383464A1

公开(公告)日：2022-12-01

申请号：US17874617

申请日：2022-07-27

Applicant: ELUCID BIOIMAGING INC.

Inventor： Andrew J. BUCKLER ,  Changguo Ji ,  Murali Ayyapillai

IPC: G06T5/50 ,  A61B6/00 ,  G06T7/00 ,  G06T7/174

Abstract: Systems and methods for improving soft tissue contrast, characterizing tissue, classifying phenotype, stratifying risk, and performing multi-scale modeling aided by multiple energy or contrast excitation and evaluation are provided. The systems and methods can include single and multi-phase acquisitions and broad and local spectrum imaging to assess atherosclerotic plaque tissues in the vessel wall and perivascular space.